Argyriou K, Parra-Blanco A. Evidence-based considerations on bowel preparation for colonoscopy. World J Gastroenterol 2022; 28(31): 4463-4466 [PMID: 36159016 DOI: 10.3748/wjg.v28.i31.4463]
Corresponding Author of This Article
Konstantinos Argyriou, MD, MSc, PhD, Academic Research, Consultant Physician-Scientist, Department of Gastroenterology, University Hospital of Larisa, Mezourlo, Larisa GR41334, Greece. kosnar2@doctors.org.uk
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Aug 21, 2022; 28(31): 4463-4466 Published online Aug 21, 2022. doi: 10.3748/wjg.v28.i31.4463
Evidence-based considerations on bowel preparation for colonoscopy
Konstantinos Argyriou, Adolfo Parra-Blanco
Konstantinos Argyriou, Department of Gastroenterology, University Hospital of Larisa, Larisa GR41334, Greece
Adolfo Parra-Blanco, Department of Gastroenterology, Nottingham University Hospitals NHS Trust, Nottingham NG51PB, United Kingdom
Author contributions: Argyriou K and Parra-Blanco A designed and performed the research; Argyriou K wrote this comment; Parra-Blanco A revised the manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Konstantinos Argyriou, MD, MSc, PhD, Academic Research, Consultant Physician-Scientist, Department of Gastroenterology, University Hospital of Larisa, Mezourlo, Larisa GR41334, Greece. kosnar2@doctors.org.uk
Received: December 20, 2021 Peer-review started: December 20, 2021 First decision: March 10, 2022 Revised: March 26, 2022 Accepted: July 24, 2022 Article in press: July 24, 2022 Published online: August 21, 2022
Abstract
We recently read with interest the article, “Novel frontiers of agents for bowel cleansing for colonoscopy”. This is a practical narrative review, which could be of particular importance to clinicians in order to improve their current practice. Although we appreciate the venture of our colleagues, based on our in-depth analysis, we came across several minor issues in the article; hence, we present our comments in this letter. If the authors consider these comments further in their relevant research, we believe that their contribution would be of considerable importance for future studies.
Core Tip: Colonoscopy is the gold standard investigation for the detection and treatment of colorectal neoplasia. The effectiveness and safety of the procedure mainly depends on the quality of bowel preparation (BP). Although international guidelines underline methods to ensure adequate BP, inadequate BP occurs in approximately one-third of the colonoscopies. The search for an ideal regimen to improve BP remains. The article by the authors addressed this issue successfully, but we detected several minor issues. Therefore, we would like to share our views and opinions on this interesting review.
